2017
DOI: 10.1016/j.biopha.2017.01.123
|View full text |Cite
|
Sign up to set email alerts
|

Sesamin imparts neuroprotection against intrastriatal 6-hydroxydopamine toxicity by inhibition of astroglial activation, apoptosis, and oxidative stress

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
22
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 49 publications
(22 citation statements)
references
References 57 publications
0
22
0
Order By: Relevance
“…Sesamin at dosage 20 ppm has shown to suppress 6-hydroxydopamine (6-OHDA) that induces Parkinson's disease in rats [43] via decrease in inflammatory mediator levels in the brain. Sesamin has the capability to alleviate astrogliosis based on the lowering effect of glial fibrillary acidic protein (GFAP) immunoreactivity.…”
Section: Neurodegenerative Diseasementioning
confidence: 99%
“…Sesamin at dosage 20 ppm has shown to suppress 6-hydroxydopamine (6-OHDA) that induces Parkinson's disease in rats [43] via decrease in inflammatory mediator levels in the brain. Sesamin has the capability to alleviate astrogliosis based on the lowering effect of glial fibrillary acidic protein (GFAP) immunoreactivity.…”
Section: Neurodegenerative Diseasementioning
confidence: 99%
“…Other reports also demonstrated that some of these constituents (sesamol, sesamolin, sesamin, and sesaminol) inhibit the proinflammatory cytokines such as TNF‐α, IL‐1β, IL‐6, and NF‐kB either in vivo rat (Bournival, Plouffe, Renaud, Provencher, & Martinoli, ; Chen et al, ; Hemshekhar et al, ; Hsu, Chu, Chandrasekaran, & Liu, ; Jeng & Hou, ; Yashaswini et al, 2017b) or in vitro cell culture model (Bournival et al, ). Sesamol, sesamolin, and sesamin also suppress the inflammatory cascade by downregulating the expression of caspase‐3 (Baluchnejadmojarad, Mansouri, Ghalami, Mokhtari, & Roghani, ; Chopra, Tiwari, Arora, & Kuhad, ; Hsieh et al, ; Hung et al, ; Jeng & Hou, ). A recent clinical trial was reported on sesamin supplementation on cardiovascular risk factors in women with rheumatoid arthritis, and the results found that sesamin research had been conducted and evaluated by Helli, Mowla, Mohammadshahi, and Jalali (), which showed protective effect of SO (Helli et al, ).…”
Section: Resultsmentioning
confidence: 99%
“…08 . Submit Manuscript also lowered malondialdehyde, caspase 3 activity, α-synuclein expression and ROS [130]. Another report by Kiyofuji et al, evidenced that supplementation of 10μM macelignan (a nutmeg lignan) to the mice midbrain slice cultures treated with IFN-γ and LPS showed dramatic effect on inflammation induced degeneration of dopaminergic neurons through expression of arginase-1 [131].…”
Section: Lignans With Anti-pd Effectmentioning
confidence: 92%